Controlled trial of D(-)penicillamine in severe rheumatoid arthritis.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000419:Albuminuria / Q000139:chemically induced; D000856:Anorexia Nervosa / Q000139:chemically induced; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002254:Carbonates / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003300:Copper / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D010396:Penicillamine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D012964:Sodium / Q000008:administration & dosage; D013431:Sulfates / Q000008:administration & dosage; D013651:Taste Disorders / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced; D013997:Time Factors
D002254:Carbonates; D010919:Placebos; D013431:Sulfates; D003300:Copper; D012964:Sodium; D010396:Penicillamine